BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 1, 2004
View Archived Issues
Sanofi-Synthelabo achieves highly favorable R&D results during past year
Read More
Merck KgaA highlights 2003 developments
Read More
Toll-like receptor 4 involved in outward arterial remodeling in vivo
Read More
Inhibition of viral replication achieved with TNX-355 in HIV-infected patients
Read More
Gabapentin found effective against tamoxifen-related hot flashes in breast cancer
Read More
Clinical benefits associated with sitaxsentan in PAH
Read More
Promising preclinical results with Vertex's Aurora kinase inhibitor VX-680
Read More
FDA agrees to dose range finding study for ISA-247
Read More
Bionomics and WEHI form ion channel drug discovery collaboration
Read More
Protez acquires assets of Influx
Read More
NanoBio anticipates initiation of phase II cold sore trials
Read More
Callisto acquires rights to novel cancer technology platform
Read More
OSI expands ongoing phase I study of OSI-461
Read More
Milestone achievement in Arena and Merck GPCR collaboration
Read More
Expansion in GenVec SARS subcontract
Read More
New phase II/III trial for Dynavax ragweed allergy product
Read More
Diatos secures financing to advance development of DTS-201
Read More
Hollis-Eden acquires Congressional Pharmaceutical
Read More
Humaspect European marketing authorization expires
Read More
Two series of kinase/phosphatase inhibitors and their use in cancer and cardiovascular disorders
Read More
Novel PPARdelta agonists identified by Sumitomo researchers
Read More
Pharmacia claims new protein kinase inhibitors for cancer and other disorders
Read More
New antibacterial agents targeting LpxC designed at Vicuron
Read More
Novel sigma receptor ligands with hypocholesterolemic activity claimed by LEK
Read More
Collaborative research results in novel purine-based antiviral agents
Read More
Novel DPP-IV inhibitors covered by Merck patent
Read More
New antidiabetic agents in early development at Aventis
Read More
Increased half-lives of engineered human IgG antibodies reported
Read More
Sosei and Arachnova in licensing agreement in stress urinary incontinence
Read More
Abraxane enters new studies in NSCLC and metastatic melanoma
Read More
SGN-30 receives orphan drug designation for T-cell lymphomas
Read More
Suppression of MS symptoms in vivo with Neurodur
Read More
Avastin approved for first-line metastatic colorectal cancer
Read More